Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?
- PMID: 24763487
- PMCID: PMC4307794
- DOI: 10.1001/jamainternmed.2014.1927
Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?
Abstract
Importance: Both dietary modification and use of statins can lower blood cholesterol. The increase in caloric intake among the general population is reported to have plateaued in the last decade, but no study has examined the relationship between the time trends of caloric intake and statin use.
Objective: To examine the difference in the temporal trends of caloric and fat intake between statin users and nonusers among US adults.
Design, setting, and participants: A repeated cross-sectional study in a nationally representative sample of 27,886 US adults, 20 years or older, from the National Health and Nutrition Examination Survey, 1999 through 2010.
Exposures: Statin use.
Main outcomes and measures: Caloric and fat intake measured through 24-hour dietary recall. Generalized linear models with interaction term between survey cycle and statin use were constructed to investigate the time trends of dietary intake for statin users and nonusers after adjustment for possible confounders. We calculated model-adjusted caloric and fat intake using these models and examined if the time trends differed by statin use. Body mass index (BMI) changes were also compared between statin users and nonusers.
Results: In the 1999-2000 period, the caloric intake was significantly less for statin users compared with nonusers (2000 vs 2179 kcal/d; P = .007). The difference between the groups became smaller as time went by, and there was no statistical difference after the 2005-2006 period. Among statin users, caloric intake in the 2009-2010 period was 9.6% higher (95% CI, 1.8-18.1; P = .02) than that in the 1999-2000 period. In contrast, no significant change was observed among nonusers during the same study period. Statin users also consumed significantly less fat in the 1999-2000 period (71.7 vs 81.2 g/d; P = .003). Fat intake increased 14.4% among statin users (95% CI, 3.8-26.1; P = .007) while not changing significantly among nonusers. Also, BMI increased more among statin users (+1.3) than among nonusers (+0.4) in the adjusted model (P = .02).
Conclusions and relevance: Caloric and fat intake have increased among statin users over time, which was not true for nonusers. The increase in BMI was faster for statin users than for nonusers. Efforts aimed at dietary control among statin users may be becoming less intensive. The importance of dietary composition may need to be reemphasized for statin users.
Figures
Comment in
-
Statins and weight gain.JAMA Intern Med. 2014 Jul;174(7):1046. doi: 10.1001/jamainternmed.2014.1994. JAMA Intern Med. 2014. PMID: 24763439 No abstract available.
-
Therapy: Caloric and fat intake in statin users.Nat Rev Endocrinol. 2014 Aug;10(8):450-1. doi: 10.1038/nrendo.2014.82. Epub 2014 Jun 3. Nat Rev Endocrinol. 2014. PMID: 24889898 No abstract available.
-
[Does statin intake influence dietary habits? - Statin users have unfavorable eating habits].Dtsch Med Wochenschr. 2014 Sep;139(39):1920. doi: 10.1055/s-0033-1353920. Epub 2014 Sep 16. Dtsch Med Wochenschr. 2014. PMID: 25225858 German. No abstract available.
-
[Does the use of statins modify calorie intake and fat consumption?].Semergen. 2015 Mar;41(2):108-9. doi: 10.1016/j.semerg.2014.08.010. Epub 2014 Oct 30. Semergen. 2015. PMID: 25440973 Spanish. No abstract available.
Similar articles
-
Therapy: Caloric and fat intake in statin users.Nat Rev Endocrinol. 2014 Aug;10(8):450-1. doi: 10.1038/nrendo.2014.82. Epub 2014 Jun 3. Nat Rev Endocrinol. 2014. PMID: 24889898 No abstract available.
-
Statins and physical activity in older men: the osteoporotic fractures in men study.JAMA Intern Med. 2014 Aug;174(8):1263-70. doi: 10.1001/jamainternmed.2014.2266. JAMA Intern Med. 2014. PMID: 24911216 Free PMC article.
-
Association between statin use and serum cholesterol concentrations is modified by whole-grain consumption: NHANES 2003-2006.Am J Clin Nutr. 2014 Oct;100(4):1149-57. doi: 10.3945/ajcn.113.074344. Epub 2014 Aug 13. Am J Clin Nutr. 2014. PMID: 25240077
-
Association between statin drug use and peripheral blood leukocyte telomere length in the National Health and Nutrition Examination Survey 1999-2002: a cross-sectional study.Ann Epidemiol. 2018 Aug;28(8):529-534. doi: 10.1016/j.annepidem.2018.04.010. Epub 2018 May 14. Ann Epidemiol. 2018. PMID: 29853162 Free PMC article.
-
Comparing the Trend of Physical Activity and Caloric Intake between Lipid-Lowering Drug Users and Nonusers among Adults with Dyslipidemia: Korean National Health and Nutrition Examination Surveys (2010-2013).Korean J Fam Med. 2016 Mar;37(2):105-10. doi: 10.4082/kjfm.2016.37.2.105. Epub 2016 Mar 25. Korean J Fam Med. 2016. PMID: 27073609 Free PMC article.
Cited by
-
Effects of mixed nuts as part of a Brazilian Cardioprotective diet on LDL-cholesterol in adult patients after myocardial infarction: a multicenter randomized controlled clinical trial.Nutr J. 2024 Oct 1;23(1):118. doi: 10.1186/s12937-024-01020-5. Nutr J. 2024. PMID: 39354558 Free PMC article. Clinical Trial.
-
Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies.Diabetes Ther. 2024 Sep;15(9):2001-2025. doi: 10.1007/s13300-024-01628-0. Epub 2024 Jul 31. Diabetes Ther. 2024. PMID: 39085746 Free PMC article. Review.
-
Relationship Between Diet Quality and Glucose-Lowering Medication Intensity Among Adults With Type 2 Diabetes: Results From the CARTaGENE Cohort.CJC Open. 2023 Sep 29;6(1):20-29. doi: 10.1016/j.cjco.2023.09.015. eCollection 2024 Jan. CJC Open. 2023. PMID: 38313340 Free PMC article.
-
Relationship Between Diet Quality and Statin Use Among Adults With Metabolic Syndrome From the CARTaGENE Cohort.CJC Open. 2023 Sep 29;6(1):11-19. doi: 10.1016/j.cjco.2023.09.014. eCollection 2024 Jan. CJC Open. 2023. PMID: 38313338 Free PMC article.
-
Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank.Br J Clin Pharmacol. 2023 Oct;89(10):2992-3004. doi: 10.1111/bcp.15793. Epub 2023 Jun 6. Br J Clin Pharmacol. 2023. PMID: 37208559 Free PMC article.
References
-
- Goodman DW, Hulley SB, Clark LT, et al. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med. 1988;148(1):36–69. - PubMed
-
- Grundy SM, Bilheimer DB, Chait A, et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA. 1993;269(23):3015–3023. - PubMed
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. - PubMed
-
- Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227–239. - PubMed
-
- Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
